Posted on September 2021

Resonant

Resonant Therapeutics has developed a data science-enabled platform for the rapid discovery of novel targets and high-affinity, functional antibodies for cancer.

back to all
Related Insight
Background Image
October 2016 | Blair Garrou

Entrepreneurial Lessons From The Twitter Saga
Background Image
September 2016 | Adrian Fortino

Need to Meet: Adrian Fortino, a thematic investor at Mercury Fund
Background Image
November 2016 | Blair Garrou

Houston VC: St. Louis should bet big on agtech, fintech